TEVA
Teva Pharmaceutical Industries Ltd
$13.01
Earnings Summary
Revenue | $4457Mn |
Net Profits | $429Mn |
Net Profit Margins | 9.63% |
Highlights
Teva Pharmaceutical Industries Ltd’s revenue jumped 14.75% since last year same period to $4457Mn in the Q4 2023. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 15.77% jump in its revenue since last 3-months.
Teva Pharmaceutical Industries Ltd’s net profit jumped 135.14% since last year same period to $429Mn in the Q4 2023. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 436.25% jump in its net profits since last 3-months.
Teva Pharmaceutical Industries Ltd’s net profit margin jumped 130.62% since last year same period to 9.63% in the Q4 2023. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 363.22% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Teva Pharmaceutical Industries Ltd post its latest quarter earnings
EPS Estimate Current Quarter | 0.51 |
EPS Estimate Current Year | 0.51 |
Highlights
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) estimates for the current quarter stand at 0.51 - a -34.14% fall from last quarter’s estimates.
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) estimates for the current year stand at 0.51.
Key Ratios
Key ratios of the Teva Pharmaceutical Industries Ltd post its Q1 2024 earnings
Earning Per Share (EPS) | 0 |
Highlights
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2024. This indicates that the Teva Pharmaceutical Industries Ltd has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-01 | 0.51 | 0 | -100% |
₹0 US Stocks a/c Opening Fee